Given an estimated $371 billion annually is needed to achieve the United Nations 2030 Sustainable Development Goals, traditional philanthropy alone will not be sufficient to meet financing needs in global health. Impact investing can play a unique role in helping the world achieve these goals.
impact investment market size
but only 7% is in health
In November 2019, we launched Johnson & Johnson Impact Ventures—an impact investment vehicle within the Johnson & Johnson Foundation that deploys investments in healthcare innovations to further our programmatic and charitable objectives. We invest in purpose driven entrepreneurs whose innovations address health workforce and healthcare challenges in low-income and diverse communities.
To pursue the best ideas that push boundaries and surface new opportunities to advance community-based health, J&J Impact Ventures works with the public, private and philanthropic sectors to catalyze investments through social impact bond and innovative finance vehicles.
In October 2021, J&J Impact Ventures announced it is putting $50 million from the Johnson & Johnson Foundation in innovative financing to work to find and support health impact entrepreneurs to improve healthcare in communities around the world where markets fail and governments alone are not able to meet the need.
Why Johnson & Johnson?
As the largest broad-based healthcare company in the world, Johnson & Johnson has an important and unique role to play in fueling innovation in human health. We are uniquely positioned to harness all our network, knowledge and expertise to help companies overcome structural barriers and scale. We also have an ability to draw on an array of traditional philanthropic tools and innovative market-based approaches such as impact investing. We cannot solve complex public health challenges alone; we hope that the new impact investing initiative—along with the broader platform for innovative finance—will help to galvanize necessary private funding towards bridging the health gap at scale.
Leveraging full scale of the Company’s assets, J&J Impact Ventures can provide not only catalytic funding, but also access to transformational technical assistance programs, mentorship and network. As part of our portfolio approach, we seek to identify opportunities and engagements where Johnson & Johnson can be instrumental in its value add, whether it’s providing short term employee engagement opportunities or executive mentorship as part of board governance.
We invite you to join us on the journey and progress towards a more equitable future where health is within the reach of everyone, everywhere.